Optimal drug treatment regimens for HIV depend on adherence
From MaRDI portal
Publication:2210076
DOI10.1016/j.jtbi.2006.12.038zbMath1451.92170OpenAlexW2074333823WikidataQ51921692 ScholiaQ51921692MaRDI QIDQ2210076
Publication date: 5 November 2020
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2006.12.038
Related Items
Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide ⋮ Dynamics of the HIV infection under antiretroviral therapy: a cellular automata approach ⋮ Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting ⋮ Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects ⋮ Impulsive SUI epidemic model for HIV/AIDS with chronological age and infection age ⋮ Unnamed Item ⋮ Modeling HIV dynamics under combination therapy with inducers and antibodies ⋮ Global behaviour of an age-infection-structured HIV model with impulsive drug-treatment strategy ⋮ MODELING MONOCYTE-DERIVED DENDRITIC CELLS AS A THERAPEUTIC VACCINE AGAINST HIV ⋮ Viral dynamics of an HIV model with pulse antiretroviral therapy and adherence ⋮ EFFECT OF TIME DELAY ON SPATIAL PATTERNS IN A AIRAL INFECTION MODEL WITH DIFFUSION
Cites Work
- Unnamed Item
- Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects
- Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects
- Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
- Non-linear dynamics models characterizing long-term virological data from AIDS clinical trials
- Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells
- Costs versus benefits: best possible and best practical treatment regimens for HIV
